Patient Rating:

4.8 out of 5

76 Patient Ratings
19 Patient Comments

Tibor Kovacsovics, M.D.

Patient Rating:

4.8 out of 5

76 Patient Ratings
19 Patient Comments

Specialties

Languages

  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-2626 Huntsman Cancer Hospital
Clinic 2C/BMT, Blood and Marrow Transplant
1950 Circle of Hope
Salt Lake City, UT 84112
Map
(801) 585-2626 Huntsman Cancer Hospital
Hematology Clinic
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Specialties

Bio

Dr. Kovacsovics brings to the University of Utah extensive expertise in the clinical management of patients with hematologic malignancies, particularly acute leukemias. In his role at the University of Utah, Dr. Kovacsovics will serve as the Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies. In his role as Associate Director of Hematologic Malignancy Clinical Research in the HCI Clinical Trials Office, he will establish a phase 1 program in hematologic malignancies, coordinate clinical research in the Division and develop a Clinical-translational Research Network suitable to carry out multicenter investigator-initiated studies in hematologic malignancies, with an emphasis on correlative science. He will also develop relationships with community practices to engage community practices in HCI-based clinical trials and increase the number of patients treated on clinical trials.

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor (Clinical)
Academic Divisions Hematology/BMT

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.9
My confidence in care provider
4.9
Time care provider spent with me
4.7
Care provider spoke using clear language
4.7
Care provider's effort to include me in decisions
4.7
Care provider's concern for questions & worries
4.8
Care provider's explanation of condition/problem
4.8
Wait time at clinic
3.6
Care provider's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

January 16, 2015

Very, very good experience from access point, etc. I am getting tired, however, of being asked to do a survey at a minimum of once a week.

November 28, 2014

I like and respect Dr. Kovacsovics, his direct manner, and straightforward manner. I appreciated his comments about re-staging my disease and the tests that would entail. I look forward to being under his care.

November 04, 2014

We spent probably 20 minutes with the nurse and maybe 1 other person in the exam room before the Doctor came in. I realize he has a lot of people to see each day but he interrupted our comments often as we made statements to him that might better explain our concerns. When we are interrupted like that and that many times, it tells me he thinks his time is worth more than our time. Also, when we are coming to a place like Huntsman for the first time, everyone is not up to speed on everything discussed. In my case, I need it repeated certainly 2 or 3 times so I get the message. In this visit with this doctor, I felt I could not do that.

October 12, 2014

I have never been treated with such kindness and concern anywhere else. I felt especially well cared for and understood by the doctors. They didn't make me feel like they only had 5 minutes to give me and they made sure we understood everything and was comfortable with all decisions made. This was the most respectful visit with a doctor I have ever had

July 07, 2014

Dr. Nance and Dr. Kovascovics have been very informative regarding my condition. I feel at ease when they explain test results to me in a manner that I can understand. They are excellent doctors.

July 06, 2014

Better than the experience at LDS hospital

June 20, 2014

My bone marrow biopsy was a "pleasant" experience. Renee talked to me the entire time and made me feel at ease during the procedure.

May 28, 2014

I have the utmost respect for Dr. Kovacsovics. He never seems too busy when he is examining me and any questions or concerns I have regarding my condition, Dr. Kovacsovics always attentively listens then explains things to me in terms I can understand. He is the utmost professional.

May 20, 2014

I noticed that Dr Tibor J Kovacsovics was a little hurry from questions and some not understand - an inter peter had a little hard time to transferred from English to ASL so hopefully next visit and have Dr Kovacsovics be a little patience and take time.

May 11, 2014

They take the time to answer all of our questions and concerns. So far the communications about treatment drugs and side-effects have been very good. That helps a lot with this chemo stuff.

April 13, 2014

Was a good experience

April 08, 2014

Dr. Kovacsovics was very courteous and explained my results and further care options clearly. Since the results so far are quite positive, I have good confidence in his judement and care recommendations.

December 07, 2013

Great.

October 07, 2013

I have already recommended the Huntsman to others. I have been to several hospitals because of my cancer and I can honestly say that this is the first hospital where I feel at home. This is also one of the only hospitals where i have not felt like I had to be my own Doctor. I trust my team and know they are keeping close watch on me. This really takes a lot of stress off my shoulders.

October 05, 2013

Excellent doctor!

September 25, 2013

I appreciated the cautious approach rather than just jumping into Chemo. I'm glad there will be more tests done and evaluated before a diagnosis and treatment plan will be advised.

August 23, 2013

As an inpatient when I expressed concern on a certain issue to my treatment I was very impressed that they had a specialist from every possible area come talk to me about my options.

April 21, 2013

good

April 16, 2013

Dr K spoke to other people about choices in my treatment but I only know of the one choice that I was told, I would really like to try something less harmful to my body.

Academic Profile

Research Interests

  • Acute Myeloid Leukemia (AML)
  • Chemotherapy
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor (Clinical)
Academic Divisions Hematology/BMT

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 213-5621 Huntsman Cancer Institute
Hematology and Hematologic Malignancies
2000 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

Dr. Kovacsovics graduated from the University of Geneva Medical School, and was a Resident in Internal Medicine at the Clinique Médicale Thérapeutique at Geneva University Hospital, Switzerland, after which he became Chief Resident at the same institution. He also completed training as a Research Assistant at the Institute of Biochemistry at the University of Lausanne, Switzerland. He then became a Clinical and Research Fellow in Medicine, Hematology-Oncology, at Massachusetts General Hospital and Brigham and Women’s Hospital, Harvard Medical School. This was followed by positions as “Chef de Clinique” and “Médecin Associé” in the Division of Hematology at Lausanne University Hospital, Switzerland, where he set up the autologous hematopoietic stem cell transplant program. In 2004 he was recruited to the Faculty at Oregon Health Science University, where he developed a program in acute leukemia, with a focus on innovative clinical trials and molecular diagnostics. Dr. Kovacsovics has served as both principal investigator and co-investigator on numerous clinical trials and grants. Many of his clinical trials focus on new agents for treatment of acute leukemias. He is a member of multiple professional societies, and was the chairman of the Swiss Leukemia Cooperative Group (SAKK) from 2002-2004. He has published over forty peer-reviewed manuscripts, and is a regular reviewer for many top Hematology journals, including Blood, American Journal of Cancer, Haematologica, and Leukemia.

Education

Education History

Type School Degree
Fellowship Brigham and Women's Hospital
Clinical and Research Fellow in Medicine, Hematology-Oncology
Clinical Fellow
Fellowship Massachusetts General Hospital
Clinical and Research Fellow in Medicine, Hematology-Oncology
Clinical Fellow
Chief Resident Clinique Médicale Thérapeutique, Geneva University Hospital
Internal Medicine
Chief Resident
Residency Clinique Médicale Thérapeutique, Geneva University Hospital
Internal Medicine
Resident
Postdoctoral Fellowship University of Lausanne
Research Assistant, Institute of Biochemistry
Postdoctoral Fellow
Professional Medical University of Geneva Medical School
Medicine
M.D.

Publications

Selected Provider Publications

Journal Article

  1. Cogle CR, Goldman DC, Madlambayan GJ, Leon RP, Al Masri A, Clark HA, Asbaghi SA, Tyner JW, Dunlap J, Fan G, Kovacsovics T, Liu Q, Meacham A, Hamlin KL, Hromas RA, Scott EW, Fleming WH (2014). Functional integration of acute myeloid leukemia into the vascular niche.LID - 10.1038/leu.2014.109 [doi]. Leukemia.
  2. Scott EC, Heitner SB, Dibb W, Meyers G, Smith SD, Abar F, Kovacsovics T, Perez-Avraham G, Stentz A, Frires R, Dibb J, Maziarz RT (2014). Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study.LID - S2152-2650(14)00045-7 [pii]LID - 10.1016/j.clml.2014.02.003 [doi]. Clin Lymphoma Myeloma Leuk.
  3. Tyner JW, Yang WF, Bankhead A 3rd, Fan G, Fletcher LB, Bryant J, Glover JM, Chang BH, Spurgeon SE, Fleming WH, Kovacsovics T, Gotlib JR, Oh ST, Deininger MW, Zwaan CM, Den Boer ML, van den Heuvel-Eibrink MM, OHare T, Druker BJ, Loriaux MM (2013). Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening. Cancer Res, 73(1), 285-96.
  4. Tyner JW, Yang WF, Bankhead A 3rd, Fan G, Fletcher LB, Bryant J, Glover JM, Chang BH, Spurgeon SE, Fleming WH, Kovacsovics T, Gotlib JR, Oh ST, Deininger MW, Zwaan CM, Den Boer ML, van den Heuvel-Eibrink MM, OHare T, Druker BJ, Loriaux MM (2013 Jan 1). KInase pathway dependence in primary human leukemias determined by rapid inhibitor screening. Cancer Res, 73(1), 285-96.
  5. Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, Ganguly S, Avigan D, Craig M, Collins R, Maris M, Kovacsovics T, Goldberg S, Seiter K, Hari P, Greiner J, Vey N, Recher C, Ravandi F, Wang ES, Vasconcelles M, Huebner D, Kantarjian HM (2012). Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial. J Clin Oncol, 30(20), 2492-9.
  6. Dunlap J, Beadling C, Warrick A, Neff T, Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K, Leeborg N, Gatter K, Braziel RM, Press R, Corless CL, Fan G (2012). Multiplex high-throughput gene mutation analysis in acute myeloid leukemia. Hum Pathol.
  7. Claxton D, Erba HP, Faderl S, Arellano M, Lyons RM, Kovacsovics T, Gabrilove J, Huebner D, Gandhi PJ, Kantarjian H (2012). Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia. Leuk Lymphoma, 53(3), 435-40.
  8. Lancet JE, Cortes JE, Hogge DE, Tallman MS, Kovacsovics T, Damon LE, Komrokji R, Solomon SR, Kolitz JE, Cooper M, Yeager AM, Louie AC, Feldman EJ (In Press). Phase II, Multicenter, Randomized, Open Label Trial of CPX-351 (cytarabine:daunorubicin) Liposome injection versus Cytarabine and Daunorubicin in Patients with Untreated AML 60-75 Years of Age. Blood.

Case Report

  1. Kelemen K, Kovacsovics T, Braziel R, Corless C, Beadling C, Fan G (2012). RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia. Leuk Lymphoma, 53(5), 999-1002.

Clinical Trials

Video & News

News

Video